CJC-1295 NO DAC

APEX BioLabs CJC-1295 (No DAC)

$54.99

WHAT IS CJC-1295 (NO DAC)?

CJC- 1295 NO DAC RESEARCH APPLICATIONS

 

CJC 1295 (No DAC) is a synthetic peptide developed as a Growth Hormone Releasing Hormone (GHRH) analogue widely studied within scientific and laboratory environments for its involvement in growth hormone signalling pathways and endocrine communication systems. Unlike the DAC-modified version, CJC 1295 (No DAC) possesses a shorter half-life, making it a commonly selected compound for controlled research involving pulsatile growth hormone pathway modelling and intermittent receptor signalling investigations.

Researchers commonly utilise CJC 1295 (No DAC) in controlled in-vitro studies involving endocrine signalling, peptide–receptor communication, growth hormone release mechanisms, and metabolic pathway investigations. Due to its short-acting profile, it has become a recognised compound of interest in studies focused on mimicking more natural growth hormone pulse activity within laboratory environments.

Its peptide structure and endocrine signalling profile have contributed to growing scientific interest within molecular biology, receptor interaction modelling, and controlled neuroendocrine research applications. Ongoing investigations continue to explore its role in peptide-mediated signalling systems and regulated endocrine communication pathways.

At APEX Peptides USA, CJC 1295 (No DAC) is supplied as a high-purity lyophilised peptide powder manufactured under strict quality-controlled standards for scientific and investigative research use only. Each sterile vial contains 5mg of CJC 1295 (No DAC) designed to support product stability, integrity, and reliable laboratory-grade handling.


PRODUCT FEATURES

  • 5mg & 10mg CJC 1295 (No DAC) per vial

  • Short-acting GHRH analogue

  • Lyophilised powder in sterile, sealed vial

  • High purity verified through third-party analytical testing

  • Tamper-evident, batch-labelled packaging

  • Suitable for laboratory and in-vitro research applications

RESEARCH APPLICATIONS

CJC 1295 (No DAC) is commonly researched in laboratory environments involving:

  • Growth hormone signalling pathway investigations

  • Pulsatile endocrine communication studies

  • Peptide–receptor interaction modelling

  • Metabolic regulation and signalling pathway analysis

  • Controlled neuroendocrine and molecular biology research

  • Structure–activity relationship investigations

Its short-acting profile has made CJC 1295 (No DAC) a valuable compound within controlled endocrine and peptide-signalling research environments. Researchers continue to investigate its role in regulated hormone pathway modelling and peptide-mediated signalling systems under controlled laboratory conditions.

https://pubchem.ncbi.nlm.nih.gov/#query=cjc+1295

THIRD-PARTY TESTED QUALITY

All CJC 1295 (No DAC) supplied by APEX Peptides USA undergoes independent third-party analytical testing to verify:

  • Purity

  • Identity

  • Batch consistency

  • Absence of contaminants

Every batch is carefully assessed to ensure laboratory-grade quality standards, consistency, and product reliability suitable for scientific research environments. Certificates of Analysis (COAs) may be available to support transparency, quality assurance, and batch verification.

At APEX Peptides USA, we prioritise manufacturing consistency and product integrity to help ensure researchers receive dependable peptide compounds for controlled investigative applications.